Renaissance Technologies’s PharMerica Corporation PMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-186,969
| Closed | -$5.48M | – | 3624 |
|
|
2017
Q3 | $5.48M | Buy |
186,969
+112,580
| +151% | +$3.15M | 0.01% | 1713 |
|
|
2017
Q2 | $1.95M | Buy |
+74,389
| New | +$1.83M | ﹤0.01% | 2276 |
|
|
2016
Q3 | – | Sell |
-49,400
| Closed | -$1.22M | – | 3596 |
|
|
2016
Q2 | $1.22M | Buy |
49,400
+4,400
| +10% | +$109K | ﹤0.01% | 2449 |
|
|
2016
Q1 | $995K | Sell |
45,000
-35,900
| -44% | -$955K | ﹤0.01% | 2601 |
|
|
2015
Q4 | $2.83M | Sell |
80,900
-68,700
| -46% | -$2.15M | 0.01% | 1884 |
|
|
2015
Q3 | $4.26M | Buy |
149,600
+119,100
| +390% | +$4M | 0.01% | 1502 |
|
|
2015
Q2 | $1.02M | Sell |
30,500
-18,900
| -38% | -$580K | ﹤0.01% | 2443 |
|
|
2015
Q1 | $1.39M | Sell |
49,400
-123,057
| -71% | -$3.06M | ﹤0.01% | 2136 |
|
|
2014
Q4 | $3.57M | Sell |
172,457
-66,374
| -28% | -$1.58M | 0.01% | 1478 |
|
|
2014
Q3 | $5.83M | Sell |
238,831
-93,069
| -28% | -$2.47M | 0.02% | 1080 |
|
|
2014
Q2 | $9.49M | Buy |
331,900
+68,285
| +26% | +$1.9M | 0.02% | 872 |
|
|
2014
Q1 | $7.38M | Buy |
263,615
+201,615
| +325% | +$4.95M | 0.02% | 1039 |
|
|
2013
Q4 | $1.33M | Buy |
62,000
+15,700
| +34% | +$285K | ﹤0.01% | 1942 |
|
|
2013
Q3 | $614K | Sell |
46,300
-148,300
| -76% | -$2M | ﹤0.01% | 2231 |
|
|
2013
Q2 | $2.7M | Buy |
+194,600
| New | +$2.76M | 0.01% | 1426 |
|
Renaissance Technologies's PMC Position: Q4 2017 in Review
Renaissance Technologies sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 186,969 shares — an estimated $5.48M sold.
Renaissance Technologies first reported a position in PMC in Q2 2013 and held it in 15 quarters. The position peaked at $9.49M in Q2 2014. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.
- Renaissance Technologies reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
- Renaissance Technologies sold 186,969 PharMerica Corporation shares in Q4 2017, an estimated $5.48M.
- Renaissance Technologies first reported a position in PharMerica Corporation in Q2 2013 and held it in 15 quarters.
- Renaissance Technologies's PharMerica Corporation position peaked at $9.49M in Q2 2014.
- 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.
Based on Renaissance Technologies's 13F filing for Q4 2017, filed 13 Feb 2018.